| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 21, 2013 | New Constructs, LLC | N/A | PFE: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 21, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 21, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | | May 20, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - PFIZER INC. (PFE-N) | 12 | $25 | | May 20, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | PFIZER INC (PFE) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | S&P Capital IQ – STARS Reports | N/A | Pfizer, Inc | 10 | $115 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | PFIZER INC (PFE) 12-months forecast | 1 | $15 | | May 17, 2013 | Reuters Investment Profile | N/A | Pfizer Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 |
|
View All Reports for PFE ... |
|
|
0.89(3.11%) 10:11AM EDT - Nasdaq Real Time Price